Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications

Int J Mol Sci. 2019 Sep 23;20(19):4706. doi: 10.3390/ijms20194706.

Abstract

The development of natural phospholipids for nanostructured drug delivery systems has attracted much attention in the past decades. Lecithin that was derived from naturally occurring in soybeans (SL) has introduced some auspicious accomplishments to the drug carrying aspect, like effectual encapsulation, controlled release, and successful delivery of the curative factors to intracellular regions in which they procure these properties from their flexible physicochemical and biophysical properties, such as large aqueous center and biocompatible lipid, self-assembly, tunable properties, and high loading capacity. Despite the almost perfect properties as a drug carrier, liposome is known to be quite quickly eliminated from the body systems. The surface modification of liposomes has been investigated in many studies to overcome this drawback. In this review, we intensively discussed the surface-modified liposomes that enhancing the targeting, cellular uptake, and therapeutic response. Moreover, the recent applications of soy lecithin-derived liposome, focusing on cancer treatment, brain targeting, and vaccinology, are also summarized.

Keywords: drug delivery system; liposome; soy lecithin; surface modification.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use*
  • Brain* / metabolism
  • Brain* / pathology
  • Humans
  • Liposomes
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Plant Lectins / chemistry
  • Plant Lectins / therapeutic use*
  • Soybean Proteins / chemistry
  • Soybean Proteins / therapeutic use*
  • Surface Properties
  • Vaccines / chemistry
  • Vaccines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Liposomes
  • Plant Lectins
  • Soybean Proteins
  • Vaccines
  • soybean lectin